Financials
- Fiscal year
- 2025
- Turnover
- €25.2m
- Profit
- €2.0m
- Solvency
- 23.1%
Turnover▲ 21.8%
Net result
20212025
HOORCENTRUM AERTS
ActiveSummary
HOORCENTRUM AERTS has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.2m and a net result of €2.0m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 34% of 4889 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741NACE 47740Warehousing and support activities for transportation NACE 52320
#2 employer in Geel, Wholesale and retail trade sector92 sites
Size
€25.2mturnover 2025
- Staff
- 124 FTE
- Equity
- €3.2m
- Profit
- €2.0m
Structure
Auditor: Finvision BedrijfsrevisorenAccounts 31 d early1 of 6 deeds read
Why 72- 2 changes of registered office in 24 months+ Size: turnover €25.2m, 124 FTE, total assets €13.9m+ Liquidity: current ratio 1.61, cash €3.9m+ Founded in 2003Show the evidence
Checked score
Score 2025
72
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 80% of its sector peers (NACE 47, medium-sized)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency
48+8
equity 23.1% of total assets
Liquidity
66+16
short-term debt 40.8% · cash 28.1%
Profitability
87+3
return on assets 14.7%
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.6%lowest value
12-2024: 0.6%● 0.0% vs 11-2024lowest value
01-2025: 0.6%● 0.0% vs 12-2024lowest value
02-2025: 2.2%▲ +286% vs 01-2025
03-2025: 2.2%● 0.0% vs 02-2025
04-2025: 2.2%▲ +2.4% vs 03-2025
05-2025: 2.2%▲ +0.7% vs 04-2025highest value
06-2025: 1.1%▼ -49.4% vs 05-2025
07-2025: 1.1%● 0.0% vs 06-2025
08-2025: 1.1%● 0.0% vs 07-2025
09-2025: 1.1%● 0.0% vs 08-2025
10-2025: 1.1%● 0.0% vs 09-2025
11-2025: 1.1%● 0.0% vs 10-2025
12-2025: 1.1%● 0.0% vs 11-2025
01-2026: 1.1%● 0.0% vs 12-2025
02-2026: 1.1%▼ -3.2% vs 01-2026
03-2026: 1.1%● 0.0% vs 02-2026
04-2026: 1.1%▲ +0.1% vs 03-2026
05-2026: 1.1%▼ -0.7% vs 04-2026
06-2026: 1.1%▼ -1.5% vs 05-2026
07-2026: 0.6%▼ -43.0% vs 06-2026
08-2026: 0.6%● 0.0% vs 07-2026
09-2026: 0.6%● 0.0% vs 08-2026
10-2026: 0.6%● 0.0% vs 09-2026
- 2 changes of registered office in 24 months raises the probability
- Size: turnover €25.2m, 124 FTE, total assets €13.9m lowers the probability for this profile
- Liquidity: current ratio 1.61, cash €3.9m lowers the probability
- Founded in 2003 lowers the probability for this profile
Credit up to €230,000 at 30 days acceptable
Liquidity ample (current ratio 1.61 against 1.31 in 2024; short-term debt: 40.8% and cash: 28.1% of total assets), but 76.9% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, medium-sized). Better than this share of them on solvency 46%, liquidity 92%, profitability 92%, growth against the median 92%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €3.2m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
31 d early
2024
70 d early
2023
44 d early
2022
17 d early
2021
27 d early
2020
26 d early
2019
54 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 23 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
05-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · full…
- Reappointment: Finvision Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Stijn Verhoeven
- Highest result since 2018net €2.0m ▲60.4%
Key points
- Positive: Equity rose in 2025from €1.4m to €3.2m ▲ 123% View
- Positive: Among the best 5% on net resultsector median €41,086 · 4,888 companies €2.0m View
- Positive: 4 years of growth in a rowturnover 2025: €25.2m 4 years View
- Positive: Always filed on timeaccounts within the deadline every year 6 years View
By topic
Board & ownership
- Auditor
- Finvision Bedrijfsrevisoren
Timeline
- Events
- 18
- Since
- 2017
- Next accounts
- by 31-07-2027
- 30-06-2026Annual accounts filed
- 05-05-2026Reappointment: Finvision Bedrijfsrevisoren BV (statutory auditor)
- 31-12-2025Highest result since 2018
Company details
- Sites
- 92
- Legal form
- Private limited company
- Activity
- Retail sale of medical and orthopaedic goods, excluding…NACE 47741
- Founded
- 13-05-2003
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.